A Risk Model Incorporating the Novel Inflammatory Biomarker CD64 for Predicting Bloodstream Infection in Suspected Cases

结合新型炎症生物标志物CD64的风险模型用于预测疑似病例的血流感染

阅读:1

Abstract

Background/Objectives: Bloodstream infection (BSI) is a significant cause of mortality. The availability of a convenient tool for predicting the risk of BSI at the early stage would be beneficial for clinicians, allowing them to improve the outcomes of BSI and avoid antibiotic overuse. Methods: A multivariate prediction model was constructed based on conventional laboratory test results and novel serum inflammatory markers in a cohort of patients with suspected BSI over a one-year period using least absolute shrinkage and selection operator (LASSO) and logistic regression. Results: BSI was confirmed in 99 (32.0%) of the 309 enrolled patients. Five readily available markers were identified as independent predictors: the presence of local infection, platelet count, and C-reactive protein, procalcitonin (PCT), and CD64 levels. A nomogram based on these five variables achieved an area under the receiver operating characteristic curve of 0.85 in predicting the risk of BSI. The nomogram was superior to PCT alone in terms of the net clinical benefits obtained in a rather wide range of threshold probabilities. Conclusions: The simple five-variable nomogram developed in this study is useful for timely prediction of individuals at high risk of BSI. It may be used in clinical practice to facilitate timely decision-making on antimicrobial treatment and avoid inappropriate overuse of antibiotics.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。